Head of Strategy and Analysis

The Opportunity: The Director, Contracting Strategy will lead the development of contracting strategies and offerings for the assigned customer segment that support brand access, business objectives, and CSL’s competitive position in the market. The role is responsible for translating brand priorities, customer needs, reimbursement dynamics, market conditions, and customer economics into actionable contracting strategies. The Director will develop contract recommendations that balance access, volume, financial value, customer needs, operational feasibility, and enterprise objectives. The role is a key member of the US Strategic Market Access organization and will work closely with the Senior Director, Commercial Contract Strategy and Innovation Lead, Contract Execution, Contract Operations, Pricing Operations, Price Modelling, Market Access Account, Marketing, Finance, Legal, Analytics, and other cross-functional partners to support the development, approval, implementation, and ongoing evaluation of contracting strategies. The incumbent will possess deep expertise in pharmaceutical contracting, strong business and financial acumen, and a thorough understanding of reimbursement, customer economics, and market access within the assigned channel.

The Role: Channel Contracting Strategy: Lead the development and evolution of contracting strategies for the assigned customer segment. Ensure strategies align with brand priorities, access goals, customer needs, market dynamics, financial objectives, and enterprise value.

Contract Offering Development: Develop customer and segment specific contract offerings, including pricing structures, performance requirements, access provisions, and other contractual elements designed to improve product access and competitiveness.

Customer and Market Insights: Maintain a deep understanding of customer business models, reimbursement dynamics, economics, decision-making processes, and emerging market trends. Brand and Access Strategy Alignment: Partner with Marketing, Market Access, Pricing, and other cross-functional stakeholders to translate brand strategies and access goals into channel-specific contracting strategies and customer value propositions.

Financial and Business-Case Development: Support the development of financial assessments and business cases for proposed contracting strategies.

Governance and Contract Approval: Develop and present contracting recommendations to appropriate governance committees. Clearly articulate the strategic rationale, customer value proposition, financial implications, risks, and expected business outcomes.

Contract Implementation and Execution Support: Partner with Contract execution, Contract Operations, Market Access Account teams, Legal, Finance, and other stakeholders to ensure approved contracting strategies are translated into executable contract terms and implemented accurately and efficiently.

Contract Performance and Optimization: Monitor contract and customer performance against approved business-case assumptions and strategic objectives.

Skills and Experience: Bachelor’s degree (BA/BS) relevant field (e.g. business or economics) - Required, MBA/Masters- Preferred

10+ years of experience in pharmaceutical or biotechnology, including significant experience in US market access, pricing, contracting or related commercial roles.

5+ years of direct experience developing or supporting pharmaceutical contracting strategies

Demonstrated experience translating brand strategy, customer insights, reimbursement dynamics, and financial analysis into actionable contracting recommendations.

Proven experience supporting financial business cases and evaluating the access, volume, gross-to-net, profitability, and strategic implications of contract offerings.

Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. To learn more about inclusion and belonging visit

If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please click here.